Team Medical Affairs News Contact

Team Medical Affairs News Contact

Back

In Vitro Activity of Eravacycline Against Clinically Significant Bacteria Isolated from Patients with Cancer

October 3, 2021

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Medical Affairs News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2023 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED